Next-Generation Bispecific Antibodies for Combinatorial T-cell activation in Cancer Immunotherapy

Research unit

INNOSUISSE

Project number

129.370 IP-LS

Project title

Next-Generation Bispecific Antibodies for Combinatorial T-cell activation in Cancer Immunotherapy

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	We will develop next-generation CD3 bispecific antibodies with delivery of costimulatory signals to enhance T-cell function and persistence in therapeutically challenging malignancies like colorectal cancer and acute myeloid leukemia, aiming for improved safety, durability, and efficacy.